Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: BOIRON

Market Cap 497M 572M 458M 429M 801M 54.79B 818M 5.46B 2.11B 26.41B 2.15B 2.1B 91.83B P/E Ratio 2024
41x
P/E Ratio 2025 16.1x
Enterprise Value 449M 517M 414M 388M 724M 49.51B 739M 4.93B 1.91B 23.86B 1.94B 1.9B 82.98B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day-1.40%
1 week+4.06%
Current month-0.70%
1 month+2.55%
3 months+5.42%
6 months-6.00%
Current year-6.93%
1 week 28.1
Extreme 28.1
29
1 month 26.1
Extreme 26.1
29.5
Current year 24.35
Extreme 24.35
30.95
1 year 20.85
Extreme 20.85
32.25
3 years 20.85
Extreme 20.85
56.5
5 years 20.85
Extreme 20.85
56.5
10 years 20.85
Extreme 20.85
92.91
Manager TitleAgeSince
Chief Executive Officer 56 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Date Insider Type Main position Quantity % Market Cap.
23-10-28Sell 858,660 4.8939%
23-10-28Sell

Director

462,964 2.6387%
23-10-28Sell

Director

4,748 0.0271%
Change 5-day change 1-year change 3-year change Capi.($)
-1.40%+4.06%+22.88%-26.18% 574M
+0.82%+2.85%-10.69%-3.81% 13.2B
-1.10%-3.69%-35.63%-56.82% 4.97B
-0.22%+1.44%-8.54%-2.82% 4.75B
-1.86%-4.58%+8.00%-21.79% 3.85B
-1.61%-1.36%+3.39%-43.28% 3.82B
-2.69%-4.42%-4.56%-10.76% 3.69B
-0.91%+0.50%-13.83%-5.90% 3.16B
-1.50%-4.55%-14.07%-32.08% 2.29B
-6.14%-4.40%-15.13%+24.40% 1.83B
Average -1.66%-1.30%-6.82%-17.90% 4.21B
Weighted average by Cap. -0.88%-0.48%-10.03%-16.55%

Financials

2024 2025
Net sales 488M 562M 449M 421M 787M 53.8B 803M 5.36B 2.08B 25.93B 2.11B 2.06B 90.16B 501M 577M 462M 433M 809M 55.29B 826M 5.51B 2.13B 26.65B 2.17B 2.12B 92.67B
Net income 11.34M 13.06M 10.45M 9.79M 18.29M 1.25B 18.67M 125M 48.26M 603M 49.04M 47.98M 2.1B 32.64M 37.62M 30.09M 28.19M 52.68M 3.6B 53.78M 359M 139M 1.74B 141M 138M 6.04B
Net Debt -49.74M -57.32M -45.85M -42.96M -80.27M -5.49B -81.94M -547M -212M -2.65B -215M -211M -9.2B -47.86M -55.15M -44.11M -41.33M -77.23M -5.28B -78.84M -526M -204M -2.55B -207M -203M -8.85B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,499
Date Price Change Volume
26-06-11 28.20 -1.40% 1,932
26-06-10 28.60 -0.35% 1,911
26-06-09 28.70 +1.06% 1,734
26-06-08 28.40 -1.39% 1,981
26-06-05 28.80 +1.77% 3,521

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!